Cargando…
Bi-specific T1 positive-contrast-enhanced magnetic resonance imaging molecular probe for hepatocellular carcinoma in an orthotopic mouse model
BACKGROUND: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality. HCC-targeted magnetic resonance imaging (MRI) is an effective noninvasive diagnostic method that involves targeting clinically-related HCC biomarkers, such as alpha-fetoprotein (AFP) or glypican-3 (GP...
Autores principales: | Ma, Xiao-Hong, Chen, Kun, Wang, Shuang, Liu, Si-Yun, Li, Deng-Feng, Mi, Yong-Tao, Wu, Zhi-Yuan, Qu, Chun-Feng, Zhao, Xin-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048532/ https://www.ncbi.nlm.nih.gov/pubmed/35582105 http://dx.doi.org/10.4251/wjgo.v14.i4.858 |
Ejemplares similares
-
Development and in vitro study of a bi-specific magnetic resonance imaging molecular probe for hepatocellular carcinoma
por: Ma, Xiao-Hong, et al.
Publicado: (2019) -
Establishment of image‐guided radiotherapy of orthotopic hepatocellular carcinoma mouse model
por: Zhou, Kaixiao, et al.
Publicado: (2023) -
The Value of Contrast-Enhanced Magnetic Resonance Imaging Enhancement in the Differential Diagnosis of Hepatocellular Carcinoma and Combined Hepatocellular Cholangiocarinoma
por: Lu, Lun, et al.
Publicado: (2022) -
Multiparameter magnetic resonance imaging of liver fibrosis in a bile duct ligation mouse model
por: Liu, Jia-Yi, et al.
Publicado: (2021) -
Carbonized paramagnetic complexes of Mn (II) as contrast agents for precise magnetic resonance imaging of sub-millimeter-sized orthotopic tumors
por: Qin, Ruixue, et al.
Publicado: (2022)